Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 44, Issue 5, 2004, Pages 423-427

  Yilmaz, Hülya ^a   Ünlüçerçi, Yesim ^b   Gürdöl, Figen ^b   Isbilen, Elif ^b   Isbir, Turgay ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Hyperhomocysteinaemia; Methylene tetrahydrofolate reductase gene; Pre eclampsia; Turkish

Indexed keywords

CYTOSINE; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); THYMINE;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREECLAMPSIA; PREVALENCE; PRIORITY JOURNAL; RESTRICTION MAPPING; THIRD TRIMESTER PREGNANCY; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; TURKEY;

EID: 8444245917     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2004.00283.x     Document Type: Article

References (29)

1. Dekker GA, de Vries JIP, Doelitzsch PM et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 1995; 173: 1042-1048.
2. Dekker GA, van Geijn HP. Endothelial dysfunction in preeclampsia. Part II. Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia; therapeutic perspectives. J Perinat Med. 1996; 24: 119-139.
3. Rajkovic A, Catalano PM, Malinow MR. Elevated homocysteine levels with preeclampsia. Obstet Gynecol. 1997; 90: 168-171.
4. Powers RW, Minich LA, Lykins DL, Ness RB, Crombleholme WR, Roberts JM. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to pre-eclampsia. J Soc Gynecol Investig. 1999; 6 74-79.
5. Wang J, Trudinger BJ, Duarte N, Wilcken DE, Wang XL. Elevated circulating homocysteine levels in placental vascular disease and associated preeclampsia. Br J Obstet Gynaecol. 2000; 107: 935-938.
6. Andersson A, Hultberg B, Brattsrom L, Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem. 1992; 30: 377-379.
7. Van der Put NM, Steegers-Theunissen RP, Frosst P et al. Mutated methylenetetrahydrofolate reductase as a risk factor for sfina bifida. Lancet. 1995; 346: 1071-1071.
8. Kluijtmans LA, van den Heuvel LP, Boers GH et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996; 58 35-41.
9. Ray JG, Laskin CA. Folic acid and homocysteine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: a systematic review. Placenta. 1999; 20: 519-529.
10. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet. 1997; 34: 525-526.
11. Grandone E, Margaglione M, Colaizze D, Caopucci G, Scianname N, Montanaro S. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to pre-eclampsia. Thromb Haemost. 1997; 77: 1052-1054.
12. Kupferminc MJ, Fait G, Many A, Gordon D, Eldor A, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999; 340: 9-13.
13. Zusterzeel PL, Visser W, Blom HJ, Peters WH, Heil SG, Steegers EA. Methylenetetrahydrofolate reductase polymorphism in preeclampsia and the HELLP syndrome. Hypertens Pregnancy. 2000; 19: 299-307.
14. Miller SA, Dykes DD, Polesky HS. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res. 1998; 16: 1215.
15. Frosst P, Blom HJ, Milos R et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995; 10: 111-113.
16. Yilmaz H, Agaçhan B, Ergen A, Ermis-Karaali Z, Isbir T. Methylene tetrahydrofolate reductase C677T mutation and left ventricular hypertrophy in Turkish patients with type II diabetes mellitus. J Biochem Mol Biol. 2004; 37: 234-238.
17. Ubbink JB, Vermaak WHJ, Bissbort S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991; 565: 441-446.
18. Sorensen TK, Malinow MR, Williams MA, King IB, Luthy DA. Elevated second-trimester serum homocysteine levels and subsequent risk of preeclampsia. Gynecol Obstet Invest. 1999; 48: 98-103.
19. Lopez-Queseda E, Vilaseca MA, Artuch R, Gomez E, Lailla JM. Homocysteine and other plasma amino acids in preeclampsia and in pregnancies without complications. Clin Biochem. 2003; 36: 185-192.
20. Mayerhofer K, Hefler L, Zeisler H et al. Serum homocysteine levels in women with preeclampsia. Wien Klin Wochenschr. 2000; 112: 271-275.
21. Raijmakers TMA, Zusterzeel PLM, Steegers APE, Peters HMW. Hyperhomocysteinemia: a risk factor for preeclampsia? Eur J Obstet Gynecol Reprod Biol. 2001; 95: 226-228.
22. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000; 72: 315-323.
23. Rigo J, Nagi B, Fintor L et al. Maternal and neonatal outcome of preeclamptic pregnancies: The potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy. 2000; 19: 163-172.
24. Kobashi K, Yamada H, Asano T et al. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Gene. 2000; 93: 122-125.
25. Laivuori A, Kaaja R, Ylikorkala O, Hiltunen T, Kontula K. 677 C→T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol. 2000; 96: 277-280.
26. Thuillier L, Chadevaux-Vekemans B, Bonnefont JP et al. Does the polymorphism C677T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease? J Inherit Metab Dis. 1998; 21: 812-822.
27. Kaiser T, Brennecke SP, Moses EK. C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Hum Hered. 2001; 51: 20-22.
28. Prasmusinto D, Skrablin S, Hofstaetter C, Fimmers R, van der Ven K. The methylenetetrahydrofolate reductase 677 C→T polymorphism and preeclampsia in two populations. Obstet Gynecol. 2002; 99: 1085-1092.
29. Livingston JC, Barton JR, Park V, Haddad B, Phillips O, Sibai BM. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol. 2001; 185: 153-157.